Similar articles

• Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.

  Wierda JM, de Wit AP, Kuizenga K, Agoston S. Wierda JM, et al. Br J Anaesth. 1990 Apr;64(4):521-3. doi: 10.1093/bja/64.4.521. Br J Anaesth. 1990. PMID: 2334630 Clinical Trial.
• Comparison of intubating conditions after administration of Org 9246 (rocuronium) and suxamethonium.

  Cooper R, Mirakhur RK, Clarke RS, Boules Z. Cooper R, et al. Br J Anaesth. 1992 Sep;69(3):269-73. doi: 10.1093/bja/69.3.269. Br J Anaesth. 1992. PMID: 1389845 Clinical Trial.
• Relative pre- and postjunctional effects of a new vecuronium analogue, Org 9426, at the rat neuromuscular junction.

  Tian L, Mehta MP, Prior C, Marshall IG. Tian L, et al. Br J Anaesth. 1992 Sep;69(3):284-7. doi: 10.1093/bja/69.3.284. Br J Anaesth. 1992. PMID: 1356399
• Rocuronium vs. succinylcholine in the emergency department: a critical appraisal.

  Mallon WK, Keim SM, Shoenberger JM, Walls RM. Mallon WK, et al. J Emerg Med. 2009 Aug;37(2):183-8. doi: 10.1016/j.jemermed.2008.07.021. Epub 2008 Dec 20. J Emerg Med. 2009. PMID: 19097730 Review.
• Newer agents for rapid sequence intubation: etomidate and rocuronium.

  Ching KY, Baum CR. Ching KY, et al. Pediatr Emerg Care. 2009 Mar;25(3):200-7; quiz 208-10. doi: 10.1097/PEC.0b013e31819a8bbf. Pediatr Emerg Care. 2009. PMID: 19287283 Review.